BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

902 related articles for article (PubMed ID: 9568807)

  • 1. Irreversible increase of serum IGF-1 and IGFBP-3 levels in GnRH-dependent precocious puberty of different etiologies: implications for the onset of puberty.
    Belgorosky A; Rivarola MA
    Horm Res; 1998; 49(5):226-32. PubMed ID: 9568807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate).
    Juul A; Scheike T; Nielsen CT; Krabbe S; Müller J; Skakkebaek NE
    J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 in girls with premature thelarche.
    Sales DS; Moreira AC; Camacho-Hübner C; Ricco RG; Daneluzzi JC; Campos AD; Martinelli CE
    J Pediatr Endocrinol Metab; 2003; 16(6):827-33. PubMed ID: 12948294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum insulin-like growth factor-I (IGF-I) and IGF binding protein-3 levels in children with precocious puberty treated with gonadotropin-releasing hormone analog without or in combination with cyproterone acetate.
    Verrotti A; Ferrari M; Sabatino G; Morgese G; Chiarelli F
    Gynecol Endocrinol; 1997 Aug; 11(4):243-50. PubMed ID: 9272420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between the GH/IGF-I axis, insulin sensitivity, and adrenal androgens in normal prepubertal and pubertal boys.
    Guercio G; Rivarola MA; Chaler E; Maceiras M; Belgorosky A
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1162-9. PubMed ID: 11889181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor-I and IGF binding protein-3 remain high after GnRH analogue therapy in girls with central precocious puberty.
    Kanety H; Karasik A; Pariente C; Kauschansky A
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):7-12. PubMed ID: 8796132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of the pituitary-gonadal axis in children with central precocious puberty: effects on growth, growth hormone, insulin-like growth factor-I, and prolactin secretion.
    Sklar CA; Rothenberg S; Blumberg D; Oberfield SE; Levine LS; David R
    J Clin Endocrinol Metab; 1991 Oct; 73(4):734-8. PubMed ID: 1909701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum concentrations of free and total insulin-like growth factor-I, IGF binding proteins -1 and -3 and IGFBP-3 protease activity in boys with normal or precocious puberty.
    Juul A; Flyvbjerg A; Frystyk J; Müller J; Skakkebaek NE
    Clin Endocrinol (Oxf); 1996 May; 44(5):515-23. PubMed ID: 8762727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty.
    Feuillan PP; Jones JV; Barnes K; Oerter-Klein K; Cutler GB
    J Clin Endocrinol Metab; 1999 Jan; 84(1):44-9. PubMed ID: 9920060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The acid-labile subunit of human ternary insulin-like growth factor-binding protein complex in girls with central precocious puberty before and during gonadotropin-releasing hormone analog therapy.
    Cisternino M; Draghi M; Lauriola S; Scarcella D; Bernasconi S; Cavallo L; De Luca F; Lomeo A; Tatò L
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4629-33. PubMed ID: 12364447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overnight levels of luteinizing hormone, follicle-stimulating hormone and growth hormone before and during gonadotropin-releasing hormone analogue treatment in short boys born small for gestational age.
    van der Kaay DC; de Jong FH; Rose SR; Odink RJ; Bakker-van Waarde WM; Sulkers EJ; Hokken-Koelega AC
    Horm Res; 2009; 71(5):260-7. PubMed ID: 19339790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like Growth Factor 1, but Not Insulin-Like Growth Factor-Binding Protein 3, Predicts Central Precocious Puberty in Girls 6-8 Years Old: A Retrospective Study.
    Escagedo PD; Deal CL; Dwyer AA; Hauschild M
    Horm Res Paediatr; 2021; 94(1-2):44-51. PubMed ID: 34098553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of growth hormone binding protein in children with normal and precocious puberty: relation to age, gender, body composition and gonadal steroids.
    Juul A; Fisker S; Scheike T; Hertel T; Müller J; Orskov H; Skakkebaek NE
    Clin Endocrinol (Oxf); 2000 Feb; 52(2):165-72. PubMed ID: 10671943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-year results of treatment with depot leuprolide acetate for central precocious puberty.
    Neely EK; Hintz RL; Parker B; Bachrach LK; Cohen P; Olney R; Wilson DM
    J Pediatr; 1992 Oct; 121(4):634-40. PubMed ID: 1403402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of medroxyprogesterone acetate on gonadotropin secretion in girls with precocious puberty.
    Warren MP; Mathews JH; Morishima A; Vande Wiele R
    Am J Med Sci; 1975; 269(3):375-81. PubMed ID: 1155493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precocious puberty in children with tumours of the suprasellar and pineal areas: organic central precocious puberty.
    Rivarola ; Belgorosky A; Mendilaharzu H; Vidal G
    Acta Paediatr; 2001 Jul; 90(7):751-6. PubMed ID: 11519977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of combined Gn-RH agonist and hGH therapy for better attining the goals in precocious puberty treatment.
    Tatò L; Saggese G; Cavallo L; Antoniazzi F; Corrias A; Pasquino AM; Cisternino M
    Horm Res; 1995; 44 Suppl 3():49-54. PubMed ID: 8719441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sexual dimorphism in the maturation of the pituitary-gonadal axis, assessed by GnRH agonist challenge.
    Potau N; Ibáñez L; Sentis M; Carrascosa A
    Eur J Endocrinol; 1999 Jul; 141(1):27-34. PubMed ID: 10407219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathophysiology of gonadotropin secretion in patients with idiopathic precocious puberty and follow up studies during and after therapy with medroxyprogesterone acetate (author's transl)].
    Aono T; Minagawa J; Terakawa N; Kurachi K; Matsumoto K
    Nihon Naibunpi Gakkai Zasshi; 1975 Nov; 51(11):898-907. PubMed ID: 1241847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of anthropomorphic and biochemical characteristics in girls with central precocious puberty and thelarche variant.
    Su PH; Wang SL; Chen JY; Chen SJ; Ke JC
    J Pediatr Endocrinol Metab; 2008 Mar; 21(3):213-20. PubMed ID: 18540247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.